Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Protein mimetic amyloid inhibitor shows antitumor activity in vivo

Oct. 5, 2021

Fochon Pharmaceuticals synthesizes new BTK inhibitors

Oct. 5, 2021

Janpix divulges new STAT5 inhibitors

Oct. 5, 2021

University of Kentucky identifies histone demethylase and Wnt signaling inhibitors

Oct. 5, 2021

Genentech patents new TEAD inhibitors

Oct. 5, 2021

GlaxoSmithKline details discovery of new class of BET BD2 inhibitors

Oct. 4, 2021

Preclinical evaluation of novel IDO1 apoenzyme inhibitors

Oct. 4, 2021

Jinan University describes new tyrosine protein kinase inhibitors for cancer

Oct. 4, 2021

Suzhou Zanrong Pharma discloses HER2 inhibitors

Oct. 4, 2021

Medshine Discovery patents new BCL2/BCL2L1 inhibitors

Oct. 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...